Ruirui Wang

Ruirui Wang

Auto-generated profile, based on publicly available information

Ruirui Wang

Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Major Chronic Non‐communicable Diseases Suzhou Medical College of Soochow University Suzhou China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
FLFanghua Liu
Fanghua Liu
PYPinni Yang
Pinni Yang
YWYinan Wang
Yinan Wang
Mengyao ShiMengyao Shi
Mengyao Shi
RWRuirui Wang
Ruirui Wang
JHJiang He
Jiang He
Background: We examined whether the relationship between baseline platelet count and clinical outcomes is modulated by HS‐CRP (high‐sensitivity C‐reactive protein) in patients with ischemic stroke. Methods and Results: A total of 3267 patients with ischemic stroke were included in the analysis. The primary outcome was a combination of death and major disability at 1 year after ischemic stroke. Secondary outcomes included major disability, death, vascular events, composite outcome of vascular events or death, and an ordered 7‐level categorical score of the modified Rankin Scale at 1 year. Multivariate logistic regression and Cox proportional hazards regression models were used to assess the association between the baseline platelet count and clinical outcomes stratified by HS‐CRP levels when appropriate. There was an interaction effect of platelet count and HS‐CRP on the adverse clinical outcomes after ischemic stroke (all P interaction <0.05). The elevated platelet count was significantly associated with the primary outcome (odds ratio [OR], 3.14 [95% CI, 1.77–5.58]), major disability (OR, 2.07 [95% CI, 1.15–3.71]), death (hazard ratio [HR], 2.75 [95% CI, 1.31–5.79]), and composite outcome of vascular events or death (HR, 2.57 [95% CI, 1.38–4.87]) among patients with high HS‐CRP levels (all P trend <0.05). Conclusions: The HS‐CRP levels had a modifying effect on the association between platelet count and clinical outcomes in patients with ischemic stroke. Elevated platelet count was significantly associated with adverse clinical outcomes in patients with ischemic stroke with high HS‐CRP levels, but not in those with low HS‐CRP levels. These findings suggest that strategies for anti‐inflammatory and antiplatelet therapy should be developed according to the results of both platelet and HS‐CRP testing.

1 October 2022 in Hypertension
Verified
Journal Article
Closed access
PDF file
RWRuirui Wang
Ruirui Wang
YLYang Liu
Yang Liu
PYPinni Yang
Pinni Yang
Zhengbao ZhuZhengbao Zhu
Zhengbao Zhu
Mengyao ShiMengyao Shi
Mengyao Shi
JHJiang He
Jiang He
BACKGROUND: Increased blood pressure (BP) variability is positively associated with the risks of cerebral small-vessel disease, cardiovascular events and death. However, no large clinical trials have been published to demonstrate the effect of BP fluctuations during hospitalization on clinical outcomes after ischemic stroke. METHODS: A total of 3972 patients with acute ischemic stroke from 26 participating hospitals were included in this study, and BP fluctuations were calculated using BP data collected during the hospitalization. The primary outcome was composite outcome of death or major disability (modified Rankin Scale score ≥3) within 3 months and secondary outcomes included death, vascular events, and composite outcomes (death or vascular events). RESULTS: Compared with the lowest quartile of systolic BP fluctuations, the adjusted odds ratio associated with the highest quartile was 1.33 ([95% CI, 1.05–1.68]; P trend =0.011) for primary outcome; the adjusted hazard ratios were 2.89 ([95% CI, 1.58–5.32]; P trend <0.001) for death, 1.48 ([95% CI, 0.83–2.65]; P trend =0.071) for vascular events, and 2.06 ([95% CI, 1.32–3.23]; P trend <0.001) for composite outcome. Similar results were found for diastolic BP. Multivariable adjusted restricted cubic spline analysis showed a linear relationship between systolic BP fluctuations and the primary outcome ( P for linearity=0.0009). CONCLUSIONS: Larger BP fluctuations during hospitalization were associated with an increased risk of adverse outcomes at 3 months after ischemic stroke onset, independent of mean BP. These findings suggested that BP fluctuation should be a risk factor of adverse outcomes after ischemic stroke, which provided a new insight for BP management strategy.

5 September 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
QXQingyun Xu
Qingyun Xu
LSLulu Sun
Lulu Sun
YWYi Wang
Yi Wang
RWRuirui Wang
Ruirui Wang
YJYiming Jia
Yiming Jia
Zhengbao ZhuZhengbao Zhu
Zhengbao Zhu
Background: Chitinase‐3 like protein 1 (CHI3L1, YKL‐40) was reported to be implicated in the development of ischemic stroke, but whether the association between them was causal remained unclear. We conducted a 2‐sample Mendelian randomization study to explore the associations of genetically determined plasma YKL‐40 with ischemic stroke and its subtypes (large artery stroke, small vessel stroke, and cardioembolic stroke). Methods and Results: Based on genome‐wide association study data of 3394 European‐descent individuals, we selected 13 single‐nucleotide polymorphisms associated with plasma YKL‐40 as genetic instruments. Summary data about ischemic stroke and its subtypes were obtained from the Multiancestry Genome‐wide Association Study of Stroke Consortium, involving 34 217 ischemic stroke cases and 406 111 controls of European ancestry. We used the inverse‐variance weighted method followed by a series of sensitivity analyses to assess the causal associations of plasma YKL‐40 with ischemic stroke and its subtypes. The primary analysis showed that genetically determined high YKL‐40 levels were associated with increased risks of large artery stroke (odds ratio [OR], 1.08 [95% CI, 1.04–1.12]; P =1.73×10 −4 ) and small vessel stroke (OR, 1.05 [95% CI, 1.01–1.09]; P =7.96×10 −3 ) but not with ischemic stroke or cardioembolic stroke. Sensitivity analyses further confirmed these associations, and Mendelian randomization‐Egger indicated no evidence of genetic pleiotropy. In addition, supplementary analysis based on the summary data from the Olink proximity extension assay cardiovascular I (Olink CVD‐I) panel showed that high YKL‐40 levels were positively associated with the risks of large artery stroke (OR, 1.15 [95% CI, 1.08–1.22]; P =4.16×10 −6 ) but not with small vessel stroke. Conclusions: Genetically determined high plasma YKL‐40 levels were causal associated with increased risks of large artery stroke.

20 July 2024 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
RWRuirui Wang
Ruirui Wang
MSMengyao Shi
Mengyao Shi
QZQilu Zhang
Qilu Zhang
JZJing Zhang
Jing Zhang
LSLulu Sun
Lulu Sun
YZYonghong Zhang
Yonghong Zhang
This study was aimed to explore the longitudinal association of five early life factors (breastfeeding, maternal smoking around birth, birth weight, being born in a multiple birth, and adoption) during the in-utero, perinatal, and early childhood development stages with incidence of depression and anxiety in adults aged 40–69 years. We used data from the UK biobank, 5,02,394 participants aged 40–69 years were recruited between 2006 and 2010. Participants provided information on early life exposures through touchscreen questionnaires or verbal interviews at baseline. The primary outcomes, depression, and anxiety, were defined according to the International Classification of Diseases, 10th Revision. Hazard ratios (HR) and 95% confidence intervals (CI) for each factor were reported. During a median follow-up of 13.6 years, 16,502 (3.55%) participants developed depression, and 15,507 (3.33%) developed anxiety. After adjusting for potential confounders, increased risk of depression was found to be significantly associated with non-breastfeeding (HR, 1.08; 95% CI, 1.04–1.13), maternal smoking around birth (HR, 1.19; 95% CI, 1.14–1.23), being born in multiple births (HR, 1.16; 95% CI, 1.05–1.27), low birth weight (HR, 1.14; 95% CI, 1.07–1.22), and being an adoptee (HR, 1.42; 95% CI, 1.28–1.58). Increased risk of anxiety was associated with non-breastfeeding (HR, 1.09; 95% CI, 1.04–1.13), maternal smoking around birth (HR, 1.11; 95% CI, 1.07–1.16), being born in a multiple births (HR, 1.05; 95% CI, 0.95–1.17), low birth weight (HR, 1.12; 95% CI, 1.05–1.20), and being an adoptee (HR, 1.25; 95% CI, 1.10–1.41). Each of these five early life factors can be considered as early life risk factors for incident depression and anxiety in adulthood independently. The dose-response relationship was also observed, suggesting that with an increase in the number of early life risk factors, the likelihood of experiencing depression and anxiety also increased. These findings highlighted the imperative consideration of early life factors in comprehending the susceptibility to mental health disorders later in life, including non-breastfeeding, maternal smoking around birth, being born in multiple births, low birth weight, and being an adoptee.

3 April 2024 in Heart
Verified
Journal Article
Closed access
PDF file
RWRuirui Wang
Ruirui Wang
YLYang Liu
Yang Liu
QZQilu Zhang
Qilu Zhang
JZJing Zhang
Jing Zhang
HPHao Peng
Hao Peng
JHJiang He
Jiang He
Objective The management of blood pressure (BP) in acute ischaemic stroke remains a subject of controversy. This investigation aimed to explore the relationship between 24-hour BP patterns following ischaemic stroke and clinical outcomes. Methods A cohort of 4069 patients who had an acute ischaemic stroke from 26 hospitals was examined. Five systolic BP trajectories were identified by using latent mixture modelling: trajectory category 5 (190–170 mm Hg), trajectory category 4 (180–140 mm Hg), trajectory category 3 (170–160 mm Hg), trajectory category 2 (155–145 mm Hg) and trajectory category 1 (150–130 mm Hg). The primary outcome was a composite outcome of death and major disability at 3 months poststroke. Results Patients with trajectory category 5 exhibited the highest risk, while those with trajectory category 1 had the lowest risk of adverse outcomes at 3-month follow-up. Compared with the patients in the trajectory category 5, adjusted ORs (95% CIs) for the primary outcome were 0.79 (0.58 to 1.10), 0.70 (0.53 to 0.93), 0.64 (0.47 to 0.86) and 0.47 (0.33 to 0.66) among patients in trajectory category 4, trajectory category 3, trajectory category 2 and trajectory category 1, respectively. Similar trends were observed for death, vascular events and the composite outcome of death and vascular events. Conclusion Patients with persistently high BP at 180 mm Hg within 24 hours of ischaemic stroke onset had the highest risk, while those maintaining stable BP at a moderate-low level (150 mm Hg) or even a low level (137 mm Hg) had more favourable outcomes.

7 February 2026 in The Journal Of Prevention of Alzheimer's Disease
Verified
Journal Article
Open access
RWRuirui Wang
Ruirui Wang
YGYijie Gao
Yijie Gao
NENicole Ee
Nicole Ee
FAFope Akinyede
Fope Akinyede
XXXiaoyue Xu
Xiaoyue Xu
RPRuth Peters
Ruth Peters
Cumulative blood pressure (cBP), reflecting long-term BP exposure, is increasingly used to examine risk associations with dementia and cognitive function, but findings to date are inconsistent. This systematic review aimed to synthesize existing evidence to clarify risk associations in adults. We searched for articles in Medline, Embase (Ovid), Web of Science, Cochrane Library, and China National Knowledge Infrastructure from inception to January 2025 in any language. Longitudinal, observational studies involving participants aged over 18 years at the time of initial BP assessment were eligible for inclusion. cBP was defined as the area under the curve of BP values over time or an equivalent method, expressed in units of mmHg × time. Study outcomes were dementia, cognitive function assessments, and neuroimaging markers. This review is registered in PROSPERO (CRD42025640637). From 6334 records identified, 10 independent prospective cohort studies from 9 publications were included in the review, of which four cohort studies were eligible for meta-analysis. Meta-analysis showed that higher cumulative systolic BP (cSBP) was associated with an increased risk of incident dementia (odds ratio [OR] 1.21, 95% CI 1.00-1.45; I² = 92.4%, P for heterogeneity<0.001), while cumulative diastolic BP (cDBP) was not associated with dementia risk (OR 0.97, 95% CI 0.72-1.32; I²=97.3%, P for heterogeneity<0.001). Among eight studies on cognitive function, five reported that higher cSBP was associated with poorer cognitive performance, while three reported non-significant results. In contrast, findings for higher cDBP were mixed, with two studies reporting adverse associations, two reporting protective associations, and three reporting null associations. Two studies linked higher cSBP and cDBP to greater white matter hyperintensity burden. Sensitivity and subgroup analyses suggested that the positive association between cSBP and dementia-related outcomes were more pronounced among middle-aged adults, whereas inverse or null associations for higher cDBP was observed in some cohorts among individuals aged ≥60 years. Higher cSBP is associated with increased risk of incident dementia and cognitive decline, whereas associations for cDBP are mixed. Given the limited evidence, future studies should incorporate age-stratified analyses and consider including cumulative pulse pressure and mean arterial pressure to further clarify the relationship between cBP and cognition.